Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: '7 hydroxy pipat maleate'

Search results for: '7 hydroxy pipat maleate'

Items 51-60 of 79

Page
per page
  1. ITF2357 (Givinostat)
    A4093 ITF2357 (Givinostat)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      ≥23.8 mg/mL
  2. Bortezomib (PS-341)
    A2614 Bortezomib (PS-341)
     24 Citation
    Target: Proteasome
    Summary: Proteasome Inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.21 mg/mL
  3. Tolcapone
    A4383 Tolcapone
    Target: Catechol O-Methyltransferase (COMT)
    Summary: COMT inhibitor
      insoluble in H2O; ≥12 mg/mL
  4. BMS-509744
    A3250 BMS-509744
    Target: ITK
    Summary: Itk inhibitor,potent and selective
      Soluble in DMSO
  5. GSK591
    B6182 GSK591
    Target: PRMT
    Summary: PRMT5 inhibitor
      ≥38 mg/mL
  6. Spautin-1
    B5873 Spautin-1
     1 Citation
    Target: Deubiquitinating enzymes (DUBs)|Autophagy
    Summary: Novel autophagy inhibitor
      insoluble in H2O; ≥13.5 mg/mL
  7. MnTBAP Chloride
    B5964 MnTBAP Chloride
    Target: Peroxynitrite
    Summary: Cell-permeable superoxide dismutase mimetic
      ≥25.4 mg/mL
  8. VR23
    B6026 VR23
    Target: Proteasome
    Summary: proteasome inhibitor
      insoluble in EtOH; insoluble in H2O; ≥45.55 mg/mL
  9. HTH-01-015
    A8890 HTH-01-015
    Target: NUAK
    Summary: NUAK1 inhibitor,highly specific and selective
      ≥23.45 mg/mL
  10. p-Cresyl sulfate
    A8895 p-Cresyl sulfate
     2 Citation
    Summary: Protein-bound uremic retention solute
      insoluble in EtOH; ≥30.1 mg/mL

Items 51-60 of 79

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 71item
  2. Natural Products 1 item
  3. Kits 1 item
  4. Lab Reagents 1 item
Reversibility
  1. Reversible 4item
  2. Irreversible 2item
Target
  1. Caspases 2item
  2. Cyclin-Dependent Kinases 4item
  3. Proteasome 3item
  4. Histone Deacetylases (HDACs) 4item
  5. PI3K 3item
  6. Raf 3item
  7. CSF-1R 1 item
  8. FLT3 2item
  9. GSK-3 2item
  10. Factor Xa 1 item
  11. VEGFR 4item
  12. PDGFR 4item
  13. c-Kit 2item
  14. RET 1 item
  15. p38 2item
  16. FGFR 1 item
  17. Deubiquitinating enzymes (DUBs) 1 item
  18. PP1 1 item
  19. PP2A 1 item
  20. MET 1 item
  21. Trk Receptors 1 item
  22. STAT 1 item
  23. Topoisomerases 1 item
  24. Cytochrome P450 (CYP450) 1 item
  25. HMG-CoA Reductases 2item
  26. c-MET 3item
  27. 5-HT2 Receptors 1 item
  28. DGAT 1 item
  29. Insulin and Insulin-like Receptors 1 item
  30. PARP 1 item
  31. ALK 1 item
  32. Myosin light chain kinases (MLCKs) 1 item
  33. D2 Receptors 1 item
  34. 5-HT1 Receptors 1 item
  35. Angiotensin-Converting Enzymes (ACEs) 1 item
  36. Autophagy 1 item
  37. COX 1 item
  38. GpIIb/IIIa receptor 1 item
  39. Peroxynitrite 1 item
  40. Ron 1 item
  41. Synthases/Synthetases 1 item
  42. Histamine H1 Receptors 1 item
  43. Phospholipases 1 item
  44. Noradrenaline reuptake 1 item
  45. cAMP 1 item
  46. Sulfonylurea receptors 1 item
  47. Peptidoglycan synthesis 1 item
  48. Nuclear Receptors 1 item
  49. Catechol O-Methyltransferase (COMT) 1 item
  50. Angiotensin AT1 Receptors 1 item
  51. DREADD Ligands 1 item
  52. PP4 1 item
  53. Ub-conjugating enzyme (E2) complex 1 item
  54. P97 ATPase 1 item
  55. ITK 1 item
  56. NUAK 1 item
  57. NOP Receptors 1 item
  58. PRMT 1 item
  59. Serotonin (5-HT) reuptake 1 item
  60. NE 1 item
  61. PIKfyve 1 item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 1 item
  3. Bladder Cancer 1 item
  4. B-lymphoid Malignancies 1 item
  5. Brain Injuries Studies 1 item
  6. Breast Cancer 7item
  7. Cancer 34item
  8. Chronic Lymphocytic Leukemia 2item
  9. Cocaine-Related Disorders 1 item
  10. Colon Cancer 3item
  11. Colorectal Cancer 7item
  12. Depression 1 item
  13. Diabetes 2item
  14. Glioblastoma 4item
  15. Glioma 1 item
  16. Hepatocellular Carcinoma 1 item
  17. Inflammatory Diseases 2item
  18. Lung Cancer 1 item
  19. Lung Carcinoma 1 item
  20. Lymphoma 5item
  21. Mantle Cell Lymphoma 2item
  22. Melanoma 2item
  23. Multiple Myeloma 4item
  24. Myeloma 1 item
  25. Neuroblastoma 2item
  26. Neurocognitive Disorders 1 item
  27. Non-small Cell Lung Cancer 3item
  28. Obsessive-Compulsive Disorder 1 item
  29. Ovarian Cancer 3item
  30. Pancreatic Cancer 2item
  31. Prostate Cancer 1 item
  32. Renal Cancer 1 item
  33. Rheumatoid Arthritis 1 item
  34. Schizophrenia 2item
  35. Thyroid Cancer 1 item
  36. Type 2 Diabetes 2item